Health Care: Drugs

Synergy Pharmaceuticals Inc (SGYP: NASDAQ)

$3.48 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 55.72M 21.79M 11.00M 11.68M
Research & Development 89.56M 78.03M 83.27M 50.63M
Operating Income before D & A (EBITDA) -145.29M -99.82M -94.28M -62.31M
Depreciation & Amortization 7.15M 4.62M 661.00K 115.00K
Interest Income 0.00 0.00 0.00 38.00K
Other Income - Net -39.93M -394.00K 1.45M 149.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -192.37M -104.84M -93.49M -62.24M
Interest Expense 13.39M 17.28M 2.88M 0.00
Pre-Tax Income -205.76M -122.12M -96.37M -62.24M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -198.61M -117.50M -95.71M -62.12M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -198.61M -117.50M -95.71M -62.12M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -198.61M -117.50M -95.71M -62.12M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-198.61M -117.50M -95.71M -62.12M
Preferred Dividends
Net Income Available To Common -198.61M -117.50M -95.71M -62.12M
Basic EPS from Continuing Ops. -1.21 -1.11 -1.02 -0.73
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.21 -1.11 -1.02 -0.73
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.21 -1.11 -1.02 -0.73
Basic Normalized Net Income/Share -1.21 -1.11 -1.02 -0.73
EPS fr Continuing Ops. -1.21 -1.11 -1.02 -0.73
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.21 -1.11 -1.02 -0.73
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.21 -1.11 -1.02 -0.73
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.21 -1.11 -1.02 -0.73
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SGYP

Latest SGYP Headlines from TheStreet

More Financial News for SGYP

Press Releases for SGYP

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter